A Study of EUR-1066 in Subjects With Chronic Pancreatitis, Exocrine Pancreatic Insufficiency and Chronic Abdominal Pain

• Status: Terminated
• Trial end date: 2011-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate two different treatments in subjects with chronic pancreatitis, exocrine pancreatic insufficiency and chronic abdominal pain.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Eurand Pharmaceuticals; Forest Laboratories
• Collaborator: University of Florida
• Treatments: Pancreatin; Pancrelipase

Criteria

Inclusion Criteria:

• Diagnosis of Chronic Pancreatitis

• Exocrine Pancreatic Insufficiency

• Chronic abdominal pain

Exclusion Criteria:

• Acute pancreatitis

• Active alcohol consumption

• Uncontrolled diabetes